Blake Paterson

1.1k total citations
14 papers, 823 citations indexed

About

Blake Paterson is a scholar working on Molecular Biology, Gastroenterology and Surgery. According to data from OpenAlex, Blake Paterson has authored 14 papers receiving a total of 823 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Gastroenterology and 3 papers in Surgery. Recurrent topics in Blake Paterson's work include Celiac Disease Research and Management (4 papers), Microscopic Colitis (3 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). Blake Paterson is often cited by papers focused on Celiac Disease Research and Management (4 papers), Microscopic Colitis (3 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). Blake Paterson collaborates with scholars based in United States, Canada and Germany. Blake Paterson's co-authors include Karen M. Lammers, Alessio Fasano, Marie‐Claire Arrieta, Jon Meddings, Joseph A. Murray, Daniel A. Leffler, Ciarán P. Kelly, Anthony M. Colatrella, Francisco León and Michael Lahn and has published in prestigious journals such as Gastroenterology, Journal of Pharmacology and Experimental Therapeutics and The American Journal of Gastroenterology.

In The Last Decade

Blake Paterson

14 papers receiving 794 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Blake Paterson United States	11	436	327	271	268	142	14	823
Fabienne Vavasseur France	15	140 0.3×	80 0.2×	147 0.5×	405 1.5×	28 0.2×	25	899
Shobha Gopalakrishnan United States	11	95 0.2×	91 0.3×	89 0.3×	250 0.9×	75 0.5×	13	485
Yuriko Minegishi Japan	16	69 0.2×	77 0.2×	184 0.7×	320 1.2×	38 0.3×	32	704
Peijian He United States	19	77 0.2×	63 0.2×	208 0.8×	667 2.5×	57 0.4×	36	925
Jorge Uribe United States	10	40 0.1×	67 0.2×	149 0.5×	416 1.6×	43 0.3×	15	814
Zsuzsanna Sandor United States	13	55 0.1×	32 0.1×	140 0.5×	188 0.7×	117 0.8×	26	528
Zhuoyuan Lin China	19	160 0.4×	58 0.2×	98 0.4×	534 2.0×	40 0.3×	44	916
Sinju Sundaresan United States	14	35 0.1×	116 0.4×	146 0.5×	411 1.5×	44 0.3×	24	945
Y. Tielemans Belgium	12	188 0.4×	253 0.8×	490 1.8×	220 0.8×	84 0.6×	18	757
Mary L. Holtz United States	10	41 0.1×	237 0.7×	72 0.3×	411 1.5×	22 0.2×	17	724

Countries citing papers authored by Blake Paterson

Since Specialization

Citations

This map shows the geographic impact of Blake Paterson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Blake Paterson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Blake Paterson more than expected).

Fields of papers citing papers by Blake Paterson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Blake Paterson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Blake Paterson. The network helps show where Blake Paterson may publish in the future.

Co-authorship network of co-authors of Blake Paterson

This figure shows the co-authorship network connecting the top 25 collaborators of Blake Paterson. A scholar is included among the top collaborators of Blake Paterson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Blake Paterson. Blake Paterson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Jones, Jermaine D., Shanna Babalonis, Ronald N. Marcus, et al.. (2019). A randomized, double‐blind, placebo‐controlled study of the kappa opioid receptor antagonist, CERC‐501, in a human laboratory model of smoking behavior. Addiction Biology. 25(4). e12799–e12799. 23 indexed citations

Garner, Rachel M., Shobha Gopalakrishnan, John A. McCauley, et al.. (2015). Preclinical pharmacology and pharmacokinetics of CERC‐301, a GluN2B‐selectiveN‐methyl‐D‐aspartate receptor antagonist. Pharmacology Research & Perspectives. 3(6). e00198–e00198. 37 indexed citations

Dicpinigaitis, Peter V., Brendan J. Canning, Rachel M. Garner, & Blake Paterson. (2014). Effect of Memantine on Cough Reflex Sensitivity: Translational Studies in Guinea Pigs and Humans. Journal of Pharmacology and Experimental Therapeutics. 352(3). 448–454. 17 indexed citations

Kelly, Ciarán P., P. H. R. Green, Joseph A. Murray, et al.. (2012). Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo‐controlled study. Alimentary Pharmacology & Therapeutics. 37(2). 252–262. 155 indexed citations

Leffler, Daniel A., Ciarán P. Kelly, Anthony M. Colatrella, et al.. (2012). A Randomized, Double-Blind Study of Larazotide Acetate to Prevent the Activation of Celiac Disease During Gluten Challenge. The American Journal of Gastroenterology. 107(10). 1554–1562. 141 indexed citations

Gopalakrishnan, Shobha, Malarvizhi Durai, Kelly M. Kitchens, et al.. (2012). Larazotide acetate regulates epithelial tight junctions in vitro and in vivo. Peptides. 35(1). 86–94. 89 indexed citations

Leffler, Daniel A., et al.. (2008). 585 A Randomized, Double-Blind Study of AT-1001 for the Prevention of Celiac Disease Activation with Gluten Challenge. Gastroenterology. 134(4). A–80. 4 indexed citations

Paterson, Blake, Karen M. Lammers, Marie‐Claire Arrieta, Alessio Fasano, & Jon Meddings. (2007). The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT‐1001 in coeliac disease subjects: a proof of concept study. Alimentary Pharmacology & Therapeutics. 26(5). 757–766. 199 indexed citations

Sapone, Anna, K. Margaretten, Barbara J. Whalen, et al.. (2005). INHIBITION OF ZONULIN‐MEDIATED INCREASED INTESTINAL PERMEABILITY BLOCKS PROGRESSION FROM PRE‐CLINICAL AUTOIMMUNITY TO TYPE 1 DIABETES IN BB/WOR RATS. Journal of Pediatric Gastroenterology and Nutrition. 41(4). 558–558. 1 indexed citations

10.

Lahn, Michael, Gabriele Köhler, Karen Sundell, et al.. (2004). Protein Kinase C Alpha Expression in Breast and Ovarian Cancer. Oncology. 67(1). 1–10. 77 indexed citations

11.

Lahn, Michael, Su Chen, Shuyu Li, et al.. (2004). Expression Levels of Protein Kinase C-α in Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 6(3). 184–189. 34 indexed citations

12.

Lahn, Michael, Kristina Sundell, Martin Gleave, et al.. (2004). Protein kinase C‐α in prostate cancer. British Journal of Urology. 93(7). 1076–1081. 23 indexed citations

13.

Lahn, Michael, et al.. (2004). The role of protein kinase C-α in malignancies of the nervous system and implications for the clinical development of the specific PKC-α inhibitor aprinocarsen (Review). Oncology Reports. 11(2). 515–22. 6 indexed citations

14.

Lahn, Michael, Blake Paterson, Kristina Sundell, & Ding Ma. (2003). The role of protein kinase C-alpha (PKC-α) in malignancies of the gastrointestinal tract. European Journal of Cancer. 40(1). 10–20. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact